<tei.2>
<teiHeader>
<fileDesc><titleStmt><title>
Missing Title
</title><publicationStmt><p>
Freddy Choi's artificial dataset for NAACL'00 paper
</p></publicationStmt><sourceDesc><p>
Brown corpus
</p></sourceDesc></fileDesc></teiHeader>

<text><body>
<p>
<s>
A proposed conflict - of - interest policy for federally funded biomedical researchers may thwart many high - technology new ventures ,  say financiers ,  researchers and university administrators . 
</s>
</p>
<p>
<s>
The National Institutes of Health policy would require researchers to cut financial ties with health - care businesses --  or lose their government money .   
</s>
</p>
<p>
<s>
Among other concerns ,  the agency says researchers with business ties are more likely to falsify findings in order to tout new drugs . 
</s>
</p>
<p>
<s>
As ties between academia and venture capital have blossomed in recent years ,  governmental fear of abuse has risen .  
</s>
</p>
<p>
<s>
But the guidelines could " make it impossible to commercialize research ,"  says Kenneth Smith ,  associate provost and vice president for research at Massachusetts Institute of Technology .   
</s>
</p>
<p>
<s>
The NIH is asking grant recipients and others for comments on the proposed guidelines until Dec .  15 . 
</s>
</p>
<p>
<s>
After that ,  it will make a final decision on the policy . 
</s>
</p>
<p>
<s>
The guidelines could foil future arrangements similar to the deal behind Lithox Inc .,  a Salem ,  Mass .,  start - up ,  says Robert Daly ,  a managing partner of TA Associates ,  a venture - capital firm .  
</s>
</p>
<p>
<s>
With $ 2 . 3 million ,  he and other investors launched Lithox last year to market a gallstone cure being developed by researchers of the University of California at San Diego .   
</s>
</p>
<p>
<s>
The researchers ,  who are being financed by the Lithox funds ,  will receive a royalty ,  or percentage of sales ,  if their research yields a commercial product . 
</s>
</p>
<p>
<s>
But because the University of California ,  like many other universities ,  shares its royalties with researchers ,  it may disqualify itself from federal funds under the proposed guidelines ,  Mr .  Daly says .    
</s>
</p>
<p>
<s>
The high - tech industry is full of the kind of arrangement that the new guidelines would affect .  
</s>
</p>
<p>
<s>
For instance ,  Commonwealth BioVentures Inc .,  a venture - capital concern ,  last month invested $ 600 , 000 to launch Amira Inc .,  a Worcester ,  Mass .,  concern that will produce pharmaceuticals .  
</s>
</p>
<p>
<s>
Scientists Rima Kaddurah - Daouk and Paul Schimmel conducted the initial research at the Massachusetts Institute of Technology .   
</s>
</p>
<p>
<s>
While Ms .  Kaddurah - Daouk left MIT to head Amira ,  Prof .  Schimmel will continue to work at MIT ,  serve on Amira 's board and own a small equity stake in the company .  
</s>
</p>
<p>
<s>
The Amira transaction is typical of the way venture - capital firms are approaching the task of commercializing biotechnology research . 
</s>
</p>
<p>
<s>
While universities develop the basic research , " venture capitalists are the ones best positioned to finance its commercialization ,"  says Gloria W .  Doubleday of Commonwealth .   
</s>
</p>
<p>
<s>
" This is the best way to transfer technology straight off the campuses of universities ."  
</s>
</p>
<p>
<s>
But the new guidelines could prevent scientists like Prof .  Schimmel from being involved with start - ups such as Amira ,  venture capitalists point out .  
</s>
</p>
<p>
<s>
And if that happens ,  the entire process of transferring technology to the marketplace could be harmed ,  they say . 
</s>
</p>
<p>
<s>
The stakes in the controversy are large .  
</s>
</p>
<p>
<s>
Last year ,  venture capitalists spent an estimated $ 600 million to finance start - up companies in medical and biotechnology businesses ,  according to the National Venture Capital Association ,  a trade group .   
</s>
</p>
<p>
<s>
Many of the deals involved transactions in which scientific institutions or researchers agreed to commercialize their work in return for an equity stake or royalties .  
</s>
</p>
<p>
<s>
In many of these deals , " venture capitalists had the inside track ,"  says Lawrence Bock of Avalon Ventures ,  La Jolla ,  Calif .   
</s>
</p>
<p>
<s>
Investors were willing to gamble on new technologies because " we had exclusive rights to those technologies ,"  he adds .    
</s>
</p>
<p>
<s>
But under the proposed guidelines ,  all federally funded research will have to be reported publicly so that anyone can capitalize on the work . 
</s>
</p>
<p>
<s>
" Without the exclusivity ,  most venture capitalists won ' t have the incentive to invest in such deals ,"  Mr .  Bock says .  
</s>
</p>
<p>
<s>
Last year ,  for example ,  Avalon and others invested $ 14 million in Athena Neurosciences Inc .,  South San Francisco ,  Calif .,  to license and develop technology for delivery of drugs to the brain . 
</s>
</p>
<p>
<s>
But before Athena was able to get an exclusive license to the technology ,  the Federal Register published most of the details , " giving all of the company 's potential competitors a chance to exploit it ,"  Mr .  Bock says .    
</s>
</p>
<p>
<s>
Athena eventually acquired exclusive rights to the technology and currently is developing it .   
</s>
</p>
<p>
<s>
But ,  says Mr .  Bock , " It was a close call ." 
</s>
</p>
<p>
<s>
The proposed guidelines could also delay ommercialization --  and force small companies to waste scarce capital ,    entrepreneurs say .   
</s>
</p>
<p>
<s>
If start - ups can ' t have early access to research being conducted at institutions , " we have to replicate it ourselves or do without the research ,"  says Ruth Emyanitoff ,  manager of business development at Applied bioTechnology Inc .,  a Cambridge ,  Mass .,  concern .   
</s>
</p>
<p>
<s>
Duplicating research is both costly and time - consuming for a start - up ,  Ms .  Emyanitoff says .   
</s>
</p>
<p>
<s>
For its part ,  NIH insists that its guidelines " should not stifle research creativity or technology transfer from the research laboratory to commercial use ."   
</s>
</p>
<p>
<s>
Universities such as Harvard and MIT should be able to develop a way to act as brokers for the individual scientists ,  says Katherine Bick ,  who oversees the huge NIH grants program as its deputy director for extramural research . 
</s>
</p>
<p>
<s>
NIH staff members believe the guidelines are essential to prevent the escalation of problems that have already begun to surface in scientific ventures .  
</s>
</p>
<p>
<s>
Not long ago ,  scientists holding stock in Spectra Pharmaceutical Services Inc .  were accused of falsifying research to boost the stock .  
</s>
</p>
<p>
<s>
Many officials are also concerned about companies getting a " free ride "  on government - sponsored research .  
</s>
</p>
<p>
<s>
A congressional subcommitee has been investigating the potential abuse from researchers holding stock in companies exploiting their research .   
</s>
</p>
<p>
<s>
Among other provisions ,  the NIH guidelines would prohibit researchers and members of their immediate families from holding stock in any company that is affected by the outcome of their research . 
</s>
</p>
<p>
<s>
Ms .  Bick ,  the NIH administrator ,   says the business and scientific community is overreacting to what the agency merely meant to be " ideas for discussion ." 
</s>
</p>
<p>
<s>
The predictions of doom are " premature ,"  she says .   
</s>
</p>
<p>
<s>
But when agencies like the NIH circulate guidelines ,  they ' ve often already formulated policy ,  veteran scientists say . 
</s>
</p>
<p>
<s>
Indeed ,  institutions already are taking note .  
</s>
</p>
<p>
<s>
On Sept .  14 ,  Harvard began circulating a conflict - of - interest policy statement that ,  in effect ,  would follow the NIH guidelines faithfully . 
</s>
</p>
<p>
<s>
The University of California at San Francisco is also circulating a memo among its scientific faculty that will restrict contact with the world of business .  
</s>
</p>
<p>
<s>
In many other institutions ,  scientists are shunning contacts with venture investors until the NIH policy is settled .   
</s>
</p>
<p>
<s>
Says Mr .  Daly ,  the venture capitalist : " It doesn ' t matter whether they call it guidelines or policy . 
</s>
</p>
<p>
<s>
The damage is already done ."  
</s>
</p>
</body></text>

</tei.2>
